Matti Aapro has been selected as a candidate for a second term on the UICC’s Board of Directors – SPCC

SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:

“Matti Aapro, SPCC President, has been selected as a candidate for a second term on the Union for International Cancer Control (UICC)‘s Board of Directors (2024-26).

As Dr Aapro said: “The members of UICC are the ones who have played and play the most important role in their regions and countries, working towards a common goal: decreasing the risk of cancer and improving the care pathway […]. These are some of the reasons why I would like to continue on the board of UICC”.

SPCC warmly invites you to endorse Dr Aapro’s candidacy and to contact all UICC Members with voting rights.

As an international oncologist with extensive global experience, he is uniquely positioned to unite the efforts required to achieve UICC’s goals.

For more information, please visit.”

Source: SPCC (Sharing Progress in Cancer Care)/LinkedIn

Matti Aapro is member of the Board of Directors of the Cancer Center, Genolier, Switzerland and of the International Union for Cancer Control (UICC). He is President of All.Can and President of Sharing Progress in Cancer Care (SPCC), both not-for-profit associations dedicated to education and improvement of the cancer patient pathway.He is Executive Board Member of the International Society for Geriatric Oncology (SIOG), on the Board of the French-speaking Society for Supportive Care (AFSOS), Past-President of the European Cancer Organisation (ECO), member of the ECO International Committee, past-President of the Multinational Association for Supportive Care in Cancer (MASCC) and Scientific Advisor with the European School of Oncology (ESO).

He is member of the Board of the French-speaking Society for Supportive Care (AFSOS) and Advisor to the Japanese Association for Supportive Care in Cancer (JASCC). He served on the Boards of the European Organization for Research and Treatment of Cancer (EORTC) and the European Society of Medical Oncology (ESMO). He has authored over 300 papers and received several prizes and honours. His main areas of interest are breast cancer, supportive care and geriatric oncology.